By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagenic recently announced a 10-for-1 reverse stock split, which took effect on May 30.

As a result of the split, each share of the company's stock was bumped up to NOK.50 ($.09) from NOK.05. After the split, the Norwegian firm had about 27 million shares of common stock outstanding.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.